Tom McCarthy is an accomplished entrepreneur and executive with extensive experience in the biotechnology sector. They founded and currently serve as Executive Chair for Pathios Therapeutics, Lucia Bio, Grey Wolf Therapeutics, and ThirtyFiveBio, focusing on innovative therapies in oncology and immunology. McCarthy's previous roles include President and CEO at Spinifex Pharmaceuticals, where they oversaw the company’s growth and eventual acquisition by Novartis. They have also held key positions as a Non-Executive Director for various organizations and as a Venture Partner at Brandon Capital. McCarthy is dedicated to advancing drug discovery and development through their leadership at Molecule to Medicine.
This person is not in the org chart
This person is not in any teams
This person is not in any offices